Status: Recruiting
Outcome Research of a European Registry Platform on Real-world Treatment Data of Patients with Advanced NMSC
This current registry study will analyze real-world data to address questions about disease characteristics and treatment patterns in NMSC patients based on the European NMSC-Registry. The overall objective is to describe characteristics, management and treatment outcomes for patients presenting with advanced NMSC (cSCC/BCC) or HR-cSCC in routine clinical practice, independent of treatments used across different European regions.
Participants needed: 1,300
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: EuMelaReg gGmbHUpdated: Mar 12, 2025Locations: 1Duration: 5 Years
Eligibility criteria
Patients aged ≥18 years at index date [+2]